BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 17158767)

  • 1. Gene expression profiling in insulinomas of Men1 beta-cell mutant mice reveals early genetic and epigenetic events involved in pancreatic beta-cell tumorigenesis.
    Fontanière S; Tost J; Wierinckx A; Lachuer J; Lu J; Hussein N; Busato F; Gut I; Wang ZQ; Zhang CX
    Endocr Relat Cancer; 2006 Dec; 13(4):1223-36. PubMed ID: 17158767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha cell-specific Men1 ablation triggers the transdifferentiation of glucagon-expressing cells and insulinoma development.
    Lu J; Herrera PL; Carreira C; Bonnavion R; Seigne C; Calender A; Bertolino P; Zhang CX
    Gastroenterology; 2010 May; 138(5):1954-65. PubMed ID: 20138042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pancreatic beta-cell-specific ablation of the multiple endocrine neoplasia type 1 (MEN1) gene causes full penetrance of insulinoma development in mice.
    Bertolino P; Tong WM; Herrera PL; Casse H; Zhang CX; Wang ZQ
    Cancer Res; 2003 Aug; 63(16):4836-41. PubMed ID: 12941803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced TGF-beta1 expression and its target genes in human insulinomas.
    Nabokikh A; Ilhan A; Bilban M; Gartner W; Vila G; Niederle B; Nielsen JH; Wagner O; Base W; Luger A; Wagner L
    Exp Clin Endocrinol Diabetes; 2007 Nov; 115(10):674-82. PubMed ID: 18058603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypermethylation of the IGF2 differentially methylated region 2 is a specific event in insulinomas leading to loss-of-imprinting and overexpression.
    Dejeux E; Olaso R; Dousset B; Audebourg A; Gut IG; Terris B; Tost J
    Endocr Relat Cancer; 2009 Sep; 16(3):939-52. PubMed ID: 19502451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pancreatic insulinomas in multiple endocrine neoplasia, type I knockout mice can develop in the absence of chromosome instability or microsatellite instability.
    Scacheri PC; Kennedy AL; Chin K; Miller MT; Hodgson JG; Gray JW; Marx SJ; Spiegel AM; Collins FS
    Cancer Res; 2004 Oct; 64(19):7039-44. PubMed ID: 15466197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations in gene expression in MEN1-associated insulinoma development.
    Serewko-Auret MM; Mould AW; Loffler KA; Duncan R; Kay GF; Hayward NK
    Pancreas; 2010 Nov; 39(8):1140-6. PubMed ID: 20531244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recognizing genes differentially regulated in vitro by the multiple endocrine neoplasia type 1 (MEN1) gene, using RNA interference and oligonucleotide microarrays.
    Stålberg P; Santesson M; Ekeblad S; Lejonklou MH; Skogseid B
    Surgery; 2006 Dec; 140(6):921-9; discussion 929-31. PubMed ID: 17188139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deregulation of anti-Mullerian hormone/BMP and transforming growth factor-beta pathways in Leydig cell lesions developed in male heterozygous multiple endocrine neoplasia type 1 mutant mice.
    Hussein N; Lu J; Casse H; Fontanière S; Morera AM; Guittot SM; Calender A; Di Clemente N; Zhang CX
    Endocr Relat Cancer; 2008 Mar; 15(1):217-27. PubMed ID: 18310289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of p27(Kip1) expression in insulinomas developed in pancreatic beta-cell specific Men1 mutant mice.
    Fontanière S; Casse H; Bertolino P; Zhang CX
    Fam Cancer; 2006; 5(1):49-54. PubMed ID: 16528608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reexpression of oncoprotein MafB in proliferative β-cells and Men1 insulinomas in mouse.
    Lu J; Hamze Z; Bonnavion R; Herath N; Pouponnot C; Assade F; Fontanière S; Bertolino P; Cordier-Bussat M; Zhang CX
    Oncogene; 2012 Aug; 31(31):3647-54. PubMed ID: 22120711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The role and mechanism of high expression of cyclin B2 in MEN1 insulinoma].
    Wu T; Huang XH
    Sheng Li Xue Bao; 2011 Dec; 63(6):555-64. PubMed ID: 22193451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Somatic mutations of the MEN1 tumor suppressor gene in sporadic gastrinomas and insulinomas.
    Zhuang Z; Vortmeyer AO; Pack S; Huang S; Pham TA; Wang C; Park WS; Agarwal SK; Debelenko LV; Kester M; Guru SC; Manickam P; Olufemi SE; Yu F; Heppner C; Crabtree JS; Skarulis MC; Venzon DJ; Emmert-Buck MR; Spiegel AM; Chandrasekharappa SC; Collins FS; Burns AL; Marx SJ; Lubensky IA
    Cancer Res; 1997 Nov; 57(21):4682-6. PubMed ID: 9354421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular genetics of malignant insulinoma.
    Pavelic K; Hrascan R; Kapitanovic S; Vranes Z; Cabrijan T; Spaventi S; Korsic M; Krizanac S; Li YQ; Stambrook P; Gluckman JL; Pavelic ZP
    Anticancer Res; 1996; 16(4A):1707-17. PubMed ID: 8712689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic regulation of the lncRNA MEG3 and its target c-MET in pancreatic neuroendocrine tumors.
    Modali SD; Parekh VI; Kebebew E; Agarwal SK
    Mol Endocrinol; 2015 Feb; 29(2):224-37. PubMed ID: 25565142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of CDKN2C/p18, CDKN1B/p27 and CDKN2B/p15 mRNA expression, and CpG methylation status in sporadic and MEN1-associated pancreatic endocrine tumours.
    Lindberg D; Akerström G; Westin G
    Clin Endocrinol (Oxf); 2008 Feb; 68(2):271-7. PubMed ID: 17803708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulinomatosis: a multicentric insulinoma disease that frequently causes early recurrent hyperinsulinemic hypoglycemia.
    Anlauf M; Bauersfeld J; Raffel A; Koch CA; Henopp T; Alkatout I; Schmitt A; Weber A; Kruse ML; Braunstein S; Kaserer K; Brauckhoff M; Dralle H; Moch H; Heitz PU; Komminoth P; Knoefel WT; Perren A; Klöppel G
    Am J Surg Pathol; 2009 Mar; 33(3):339-46. PubMed ID: 19011561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased expression and promoter methylation of the menin tumor suppressor in pancreatic ductal adenocarcinoma.
    Cavallari I; Silic-Benussi M; Rende F; Martines A; Fogar P; Basso D; Vella MD; Pedrazzoli S; Herman JG; Chieco-Bianchi L; Esposito G; Ciminale V; D'Agostino DM
    Genes Chromosomes Cancer; 2009 May; 48(5):383-96. PubMed ID: 19170121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A mouse model of multiple endocrine neoplasia, type 1, develops multiple endocrine tumors.
    Crabtree JS; Scacheri PC; Ward JM; Garrett-Beal L; Emmert-Buck MR; Edgemon KA; Lorang D; Libutti SK; Chandrasekharappa SC; Marx SJ; Spiegel AM; Collins FS
    Proc Natl Acad Sci U S A; 2001 Jan; 98(3):1118-23. PubMed ID: 11158604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accelerated proliferation and differential global gene expression in pancreatic islets of five-week-old heterozygous Men1 mice: Men1 is a haploinsufficient suppressor.
    Lejonklou MH; Barbu A; Stålberg P; Skogseid B
    Endocrinology; 2012 Jun; 153(6):2588-98. PubMed ID: 22492302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.